Oculis Holding AG is a pharmaceutical company that focuses on developing and commercializing innovative eye therapies. Through their proprietary technology, they aim to revolutionize ocular drug delivery and improve treatment options for various eye diseases. With a strong pipeline of promising candidates, Oculis Holding is poised for growth and is at the forefront of advancements in ophthalmology.
